A recent meta-analysis of 15 case-control studies did not find any overall association [ 22 ] but this analysis was criticized by Feigelson and colleagues [ 23 ], who found a borderline significant association between the CYP17 polymorphism and advanced breast cancer.
← all excerpts
CYP17 gene polymorphism in relation to breast cancer risk: a case-control study.
1
—
—